Searching for COVID-19 treatments: First, do no harm.

Guharoy, Roy; Krenzelok, Edward

Guharoy, Roy; Krenzelok, Edward.

Guharoy R; Department of Pharmacy, Baptist Health, Montgomery, AL.
Krenzelok E; University of Massachusetts Medical School, Worcester, MA.

Am J Health Syst Pharm ; 77(22): 1899-1905, 2020 10 30.

Article in English | MEDLINE | ID: covidwho-693034

Subject(s)

Antiviral Agents/adverse effects; Antiviral Agents/therapeutic use; Coronavirus Infections/drug therapy; Pneumonia, Viral/drug therapy; Azithromycin/adverse effects; Azithromycin/therapeutic use; COVID-19; Drug Repositioning; Evidence-Based Medicine; Hemorrhagic Fever, Ebola/drug therapy; Humans; Hydroxychloroquine/adverse effects; Hydroxychloroquine/therapeutic use; Observational Studies as Topic; Pandemics; Randomized Controlled Trials as Topic; COVID-19 Drug Treatment

Keywords

Food and Drug Administration; evidence-based practice; hydroxychloroquine; randomized clinical trial

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Pneumonia, Viral / Coronavirus Infections Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Am J Health Syst Pharm Journal subject: Pharmacy / Hospitals Year: 2020 Document Type: Article Affiliation country: Ajhp

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google